Multiple-Ascending Dose in Japanese Patients Bridging Study

NCT05065359 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Rodatristat Ethyl 300 mg BID
DRUG: Rodatristat Ethyl 600 mg BID
DRUG: Placebo

Sponsor

Altavant Sciences GmbH

Collaborators

[object Object]